No two days look alike, and anyone who tells you otherwise is describing a slow week. But the work reliably breaks into the same small set of categories, and it is worth seeing that shape before you accept an offer rather than after. The job looks different from the outside than it does from a desk inside it — mostly because the parts that are visible from outside, like a clearance letter or a headline about an approval, are the smallest part of what actually fills the hours.
The four things that fill most days
Reading and tracking takes up a steady baseline of time: regulation and guidance updates, competitor clearances and approvals, and the status of whatever is already in the pipeline. Writing fills most of the rest — submission sections, responses to health authority correspondence (see working with an FDA reviewer for what that specific writing looks like), and internal rationale memos that never leave the company but still have to hold up to scrutiny. Cross-functional coordination — meetings and follow-ups with quality, clinical, R&D, and manufacturing — is where regulatory affairs earns its reputation as the function that sits at the seam between everyone else’s work. And administrative tracking — deadlines, document control, listing and registration upkeep — is unglamorous but constant; see our free 510(k) course for what a single submission’s own internal structure looks like once it is assembled.
Why the pace is uneven
A submission deadline compresses weeks of preparation into a hard date. A deficiency request opens a fixed window to respond, and that window does not move for a colleague’s vacation or a slow week elsewhere in the business. Between those events, the pace is genuinely calmer — tracking, reading, and the kind of steady document custody that rarely makes it into a job posting. The submission-to-clearance lesson covers the review clock’s actual mechanics; the point here is simpler: the calendar, not the workload itself, is what drives the rhythm.
- Reading and writing take up more of a typical week than any single meeting does — most of the actual output is a document, not a conversation.
- Coordination meetings are frequent but usually short; the substantive work happens in the writing that follows them, not in the room.
- Direct FDA correspondence is the least frequent category by far, and the most consequential per instance.
- Administrative tracking — deadlines, listings, document control — is constant and unglamorous, and neglecting it is what turns a routine week into a scramble.
Two assumptions that don’t survive the first month
Assuming the job is mostly agency contact
Reviewer correspondence is the part of the job most visible from outside it, so it is easy to imagine the work as a running dialogue with FDA. In practice, most of a regulatory professional’s week is spent on internal documents that never leave the company, in service of the few pieces of correspondence that do.
Assuming the pace stays constant
The job’s rhythm is lumpy by design — a submission deadline or a deficiency-response window compresses weeks of work into days, and expecting a steady, evenly paced workload sets up a bad surprise the first time a real deadline lands.
Sources & further reading
- 21 CFR Part 807, Subpart E — Premarket Notification Procedures, the regulatory backbone behind a device submission’s day-to-day tracking ecfr.gov
- Regulatory Academy — Working With an FDA Reviewer During a Submission regulatoryacademy.com
- Regulatory Academy — The 510(k) Pathway, a free five-lesson course regulatoryacademy.com
This essay is provided for general educational purposes and reflects the regulatory landscape as of its publication date. It is not legal, regulatory, or career advice.
